Key points are not available for this paper at this time.
This study provides clinical support for an emerging paradigm in cancer immunotherapy, wherein optimal use of vaccination might be more effective, not as a separate modality, but in direct combination with chemotherapy.
Antonia et al. (Wed,) studied this question.